Drug interactions
Linagliptin-metformin + Pegvisomant
Severity: Minor
Linagliptin-metformin and Pegvisomant: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Pegvisomant blocks growth hormone action and can improve insulin sensitivity, lowering glucose in patients with acromegaly and diabetes. This may increase the glucose-lowering effect of metformin and linagliptin.
What this interaction means in plain words
Linagliptin-metformin and Pegvisomant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Linagliptin-metformin belongs to Endocrine; Pegvisomant belongs to Endocrine.
Why it happens
Additive pharmacodynamic effect via growth hormone receptor antagonism and improved insulin sensitivity.
What to do
Monitor blood glucose after starting pegvisomant and reduce antidiabetic doses if glucose falls.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin-metformin and Pegvisomant, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Pegvisomant
- Alogliptin-metformin + Pegvisomant Moderate
- Alogliptin-pioglitazone + Pegvisomant Moderate
- Chlorpropamide + Pegvisomant Moderate
- Codeine + Pegvisomant Moderate
- Dapagliflozin-metformin + Pegvisomant Moderate
- Ertugliflozin-sitagliptin + Pegvisomant Moderate
Frequently asked questions
Can I take Linagliptin-metformin with Pegvisomant?
MediHelp rates the interaction as minor. Linagliptin-metformin and Pegvisomant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pegvisomant blocks growth hormone action and can improve insulin sensitivity, lowering glucose in patients with acromegaly and diabetes. This may increase the glucose-lowering effect of metformin and linagliptin.
How serious is the interaction between Linagliptin-metformin and Pegvisomant?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after starting pegvisomant and reduce antidiabetic doses if glucose falls.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
